AstraZeneca was exposed to divest heavy breathing products, set up a new company to take over
Recently, industry sources said that AstraZeneca will form a new company with a "Chinese" investment company, and AstraZeneca will transfer its respiratory product line to this new company, and complete the staff signing before July 1.
According to analysts, AstraZeneca spun off the new company mainly because of the impact of pooling. Due to the contraction of profits, the related products will gradually become the company's non-core assets, and the newly established company mainly manages some of the collected product lines divested by the company, and more collected products are expected to be transferred in the future, such as the digestion product line.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-08-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
AstraZeneca and CSPC Strengthen Biologics Manufacturing Partnership in China
-
China's Ibuprofen Export Performance, First Half of 2026
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
$15 Billion Invested in China: AstraZeneca Builds an “Innovation Hub” While Some Are Still Waiting for the Windfall
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
The relationship between Digital Transformation and Work- Life Balance in the Egyptian Pharmaceutical Industry
-
AstraZeneca to Invest $2.5 Billion to Establish Global Drug R&D Center in Beijing
-
AstraZeneca to invest $3.5 billion in the United States
Recommend Reading
-
![BioNTech’s Founders Turn the Page]()
BioNTech’s Founders Turn the Page
-
![Deméter Enters China with a Stress-Focused Pitch]()
Deméter Enters China with a Stress-Focused Pitch
-
![Novo Nordisk Faces a Compliance Test]()
Novo Nordisk Faces a Compliance Test
-
![EU Clears Bayer-KWS Sugar Beet Event]()
EU Clears Bayer-KWS Sugar Beet Event
-
![EU Clears Bayer-KWS Sugar Beet Event]()
EU Clears Bayer-KWS Sugar Beet Event
-
![ADAMA Targets Sucking Pests with Ateka]()
ADAMA Targets Sucking Pests with Ateka
-
![EFSA Reviews Clodinafop Risk]()
EFSA Reviews Clodinafop Risk
-
![EFSA Reviews Clodinafop Risk]()
EFSA Reviews Clodinafop Risk
-
![How Geopolitical Conflicts in the Middle East Ignite the Melamine Market with a Monthly Price Increase of Nearly 27% in China!]()
How Geopolitical Conflicts in the Middle East Ignite the Melamine Market with a Monthly Price Increase of Nearly 27% in China!
-
![Positive Factors Drive March Butanol Price Increase by Over 40%]()
Positive Factors Drive March Butanol Price Increase by Over 40%
